ELAB vs IONS · rev $2.0M vs rev $514.0M
Elevai Labs, Inc. Common Stock (ELAB) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
ELAB currently screens at market cap $6.5M. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ELAB and IONS stock pages for the full models.
Not investment advice.